Literature DB >> 22020900

Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease.

Michelle R Denburg1, Kevin Haynes, Justine Shults, James D Lewis, Mary B Leonard.   

Abstract

PURPOSE: Chronic kidney disease (CKD) is a prevalent and important outcome and covariate in pharmacoepidemiology. The Health Improvement Network (THIN) in the UK represents a unique resource for population-based studies of CKD. We compiled a valid list of Read codes to identify subjects with moderate to advanced CKD.
METHODS: A cross-sectional validation study was performed to identify codes that best define CKD Stages 3-5. All subjects with at least one non-zero measure of serum creatinine after 1 January 2002 were included. Estimated glomerular filtration rate (eGFR) was calculated according to the Schwartz formula for subjects aged < 18 years and the Modification of Diet in Renal Disease formula for subjects aged ≥ 18 years. CKD was defined as an eGFR <60 mL/minute/1.73 m² on at least two occasions, more than 90 days apart.
RESULTS: The laboratory definition identified 230,426 subjects with CKD, for a period prevalence in 2008 of 4.56% (95%CI, 4.54-4.58). A list of 45 Read codes was compiled, which yielded a positive predictive value of 88.9% (95%CI, 88.7-89.1), sensitivity of 48.8%, negative predictive value of 86.5%, and specificity of 98.2%. Of the 11.1% of subjects with a code who did not meet the laboratory definition, 83.6% had at least one eGFR <60. The most commonly used code was for CKD Stage 3.
CONCLUSIONS: The proposed list of codes can be used to accurately identify CKD when serum creatinine data are limited. The most sensitive approach for the detection of CKD is to use this list to supplement creatinine measures.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020900      PMCID: PMC3245984          DOI: 10.1002/pds.2203

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  20 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Evaluation of renal function during childhood.

Authors:  B A Atiyeh; S S Dabbagh; A B Gruskin
Journal:  Pediatr Rev       Date:  1996-05

3.  Current chronic kidney disease practice patterns in the UK: a national survey.

Authors:  A Ahmad; P Roderick; M Ward; R Steenkamp; R Burden; D O'Donoghue; D Ansell; T Feest
Journal:  QJM       Date:  2006-02-23

4.  Identifying patients with chronic kidney disease from general practice computer records.

Authors:  Simon de Lusignan; Tom Chan; Paul Stevens; Donal O'Donoghue; Nigel Hague; Billy Dzregah; Jeremy Van Vlymen; Mel Walker; Sean Hilton
Journal:  Fam Pract       Date:  2005-04-06       Impact factor: 2.267

5.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

6.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

Authors:  Marc Froissart; Jerome Rossert; Christian Jacquot; Michel Paillard; Pascal Houillier
Journal:  J Am Soc Nephrol       Date:  2005-01-19       Impact factor: 10.121

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Expressing glomerular filtration rate in children.

Authors:  D C Heilbron; M A Holliday; A al-Dahwi; B A Kogan
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

9.  The LMS method for constructing normalized growth standards.

Authors:  T J Cole
Journal:  Eur J Clin Nutr       Date:  1990-01       Impact factor: 4.016

Review 10.  Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective.

Authors:  Richard N Fine
Journal:  Pediatr Nephrol       Date:  2009-12-24       Impact factor: 3.714

View more
  31 in total

1.  Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.

Authors:  Ronac Mamtani; Kevin Haynes; Warren B Bilker; David J Vaughn; Brian L Strom; Karen Glanz; James D Lewis
Journal:  J Natl Cancer Inst       Date:  2012-08-09       Impact factor: 13.506

2.  Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices.

Authors:  Nicole Fett; Kevin Haynes; Kathleen Joy Propert; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2014-01-28       Impact factor: 11.527

3.  Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Authors:  Ravy K Vajravelu; Lawrence Copelovitch; Mark T Osterman; Frank I Scott; Ronac Mamtani; James D Lewis; Michelle R Denburg
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-01       Impact factor: 11.382

4.  Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.

Authors:  D E Freedberg; K Haynes; M R Denburg; B S Zemel; M B Leonard; J A Abrams; Y-X Yang
Journal:  Osteoporos Int       Date:  2015-05-19       Impact factor: 4.507

5.  Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.

Authors:  Christopher V Almario; David C Metz; Kevin Haynes; Yu-Xiao Yang
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-11       Impact factor: 2.566

6.  Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD.

Authors:  Claire E Lefebvre; Kristian B Filion; Pauline Reynier; Robert W Platt; Michael Zappitelli
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

7.  Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.

Authors:  Ana Beatriz Vargas-Santos; Christine E Peloquin; Yuqing Zhang; Tuhina Neogi
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

8.  Distinguishing incident and prevalent diabetes in an electronic medical records database.

Authors:  Ronac Mamtani; Kevin Haynes; Brian S Finkelman; Frank I Scott; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-12-19       Impact factor: 2.890

9.  Chronic kidney disease: Psoriasis--a risk factor for chronic kidney disease?

Authors:  Christopher K Farmer; Paul E Stevens
Journal:  Nat Rev Nephrol       Date:  2013-11-26       Impact factor: 28.314

10.  Identification of Patients with CKD in Medical Databases: A Comparison of Different Algorithms.

Authors:  Søren Viborg Vestergaard; Christian Fynbo Christiansen; Reimar Wernich Thomsen; Henrik Birn; Uffe Heide-Jørgensen
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-11       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.